AssayIndex

AX-2025-020420

KPV · 5 mg declared · Xi'an Mokemei Biotechnology Co., Ltd. · lot MKM-2504-N4868

FAILVERIFIED
Report ID
AX-2025-020420
Compound
KPV
Compound class
Tissue-repair and immunomodulatory peptides
Supplier
MKM — Xi'an Mokemei Biotechnology Co., Ltd.
Batch / lot
MKM-2504-N4868
Declared label claim
5mg
Laboratory
Janoshik Analytical
Assay date
05 May 2025
Submitted
08 May 2025
Quarter
2025-Q2
Submitter
s.weiss
Sample provenance
Buyer-sourced
Section 1

Results

Measured against the index acceptance specification for the tissue-repair and immunomodulatory peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.

ParameterMethodResultUnitIndex spec
PurityRP-HPLC, 30 min gradient, 214 nm99.66% area≥ 99.0PASS
Total impuritiesRP-HPLC, sum of reported peaks0.34% area≤ 1.0PASS
Largest single impurityRP-HPLC — Pro-Val dipeptide (−128 Da)0.15% area≤ 1.00PASS
Identity — theoretical monoisotopic masscalculated from molecular formula342.2267DaNOT TESTED
Identity — observed monoisotopic massLC-MS, high resolution (ESI-TOF/QTOF)342.2254DaNOT TESTED
Mass accuracyobserved vs theoretical-3.9ppm± 15PASS
Total peptide contentby difference from the gravimetric mass balance79.65%w/wNOT TESTED
Target-compound contenttotal peptide content × purity79.38%w/wNOT TESTED
Gross fill (as weighed)five-place balance, under nitrogen5.91mg5 mg declaredNOT TESTED
Recovered target peptidegross fill × target content4.691mg5 mg claimNOT TESTED
Recovery against label claimrecovered ÷ claim93.8%90.0 – 110.0PASS
Water contentKarl Fischer, coulometric, duplicate5.08%≤ 10.0PASS
Counter-ion (acetate)anion-exchange ion chromatography14.72%≤ 12.0FAIL
Residual solvent + inorganic residueestimated — see /methods/residual-solvents-q3c/0.55%NOT TESTED
Endotoxinnot ordered on this submissionnot determined≤ 5.0NOT TESTED
Sterilitynot ordered on this submissionnot determinedno growthNOT TESTED
Appearancevisual, diffuse light, black and white backgroundWhite to pale-yellow cake, intactwhite to off-white intact cakePASS
Reconstitution clarityreconstituted per submitter procedureClear after 90 s gentle swirling, no particulatesclear, no visible particulatesPASS
pH (reconstituted, 1 mg/mL)potentiometric, two-point calibration6.152.5 – 8.0PASS
Retention time (observed)RP-HPLC, 30 min gradient5.27min5.24 ± 0.20 (normalised)PASS
Peak asymmetry (10 % height)Ph. Eur. 2.2.460.910.80 – 1.50PASS
Plate count, main peakN = 5.54 (t/w½)²78,936≥ 20,000PASS
Resolution to nearest impurityvs diketopiperazine (−18 Da)1.95no index criterionREPORTED
Section 2

Chromatogram and peak integration

The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.

06440128801932025760 KPV5.27 min · 99.66 % 4.83 same trace · ×200 vertical expansion, baseline-corrected · main peak off-scale reporting threshold 0.05 % area 05101520253035 Retention time (min) Response (mAU)
Figure 1. RP-HPLC trace, 30 min gradient, 214 nm. Drawn from the peak-integration table below: peak positions are the reported retention times, peak areas are the reported area percentages, peak widths follow the reported plate count of 78,936, and skew follows the reported asymmetry factor of 0.91. Baseline noise is seeded from the report ID and is illustrative. The lower panel is the same trace at a stated vertical expansion with the slow gradient drift subtracted, because at full scale a 0.15 % impurity against a 99.66 % main peak is a line two pixels tall; the main peak runs off-scale there by design.
#PeakRTArea (µV·s)% areaΔ mass (Da)
1KPV — main peak5.274,843,78599.66
2Pro-Val dipeptide (−128 Da)4.837,2900.15-128.095
3diketopiperazine (−18 Da)5.424,8600.10-18.011
4Lys-Pro dipeptide (−99 Da)4.912,4300.05-99.068
5acetyl-KPV (+42 Da)5.571,9440.04+42.011
Closure check — purity + Σ impurities 100.00CLOSES

Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.

Section 3

Mass spectrum and identity

Theoretical monoisotopic mass 342.2267 Da, computed from C16H30N4O4. All ppm figures on this site are against monoisotopic values — see why that matters.

0255075100300325350375400425 [M+1H]1+343.23 m/z Relative abundance (%)
Figure 2. ESI charge-state envelope, high-resolution instrument. Sticks are placed at m/z = (M + z × 1.007276)/z for the observed neutral mass of 342.2254 Da. Sodium (+21.982/z) and potassium (+37.956/z) adducts are shown where the parent charge state exceeds 25 % relative abundance; they are adducts of the same molecule and are not impurities.
ChargeTheoretical m/zObserved m/zΔ m/zRel. abundance (%)
1+343.2340343.2327-0.0013100.0
Section 4

Gravimetric mass balance

Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.

ComponentDetermination%w/w of cake
WaterKarl Fischer5.08
Counter-ion (acetate)ion chromatography14.72
Residual solvent + inorganic residueestimated0.55
Total peptide contentby difference79.65
Total100.00 CLOSES

Supplier certificate, as declared

The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.

FigureSupplier COAThis reportIndex note
Purity (% area)99.1099.66divergence -0.80 pp vs batch median
Total impurities (% area)0.900.34
Largest single impurity (% area)0.440.15
Water (%)not stated5.08
Counter-ion (%)not stated14.72
Peptide content (%w/w)not stated79.65
Endotoxin (EU/mg)not statednot determined
Method stated on certificateYEScolumn, gradient and wavelength given
Section 5

Provenance and caveats

Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.

Sample provenance
Buyer-sourced
Evidentiary weight
Strongest available evidence in this index.
Chain of custody
Retail purchase → third-party forwarder (31 d) → laboratory (courier, cold pack, 9 d) → assay.
Assay date
05 May 2025
Submitted to the index
08 May 2025
Laboratory
Janoshik Analytical, Ostrava, Czechia
Method basis
30 min gradient · high-resolution MS
Verification status
VERIFIED
Section 6

Annotations 3

Signed technical comments from index contributors. Not a discussion forum — annotations question or contextualise the result, and the data team replies where a reply is warranted.

mass_defect
Every named impurity on this record has a mass defect consistent with its structural assignment. That is the check that distinguishes an assignment from a guess.
buyer_sourced
Independently purchased, at the submitter's own cost, forwarded without the supplier's involvement. That is the definition and this record meets it.
multiple_compare
Restricting every supplier comparison to buyer-sourced records is the sensitivity analysis the scorecards publish. On the current dataset it changes no ordering that was not already inside measurement noise.
Section 7

Related records

Same batch — lot MKM-2504-N4868 n=12

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020421MKM-2504-N4868Medutest2025-Q299.934.4189.0Supplier-supplied1FAIL
AX-2025-020422MKM-2504-N4868Medutest2025-Q299.935.28Laboratory-retained0FAIL
AX-2025-020423MKM-2504-N4868Janoshik2025-Q299.435.57102.2Buyer-sourced0PASS
AX-2025-020424MKM-2504-N4868PeptideMeter2025-Q299.935.47Buyer-sourced0PASS
AX-2025-020425MKM-2504-N4868Janoshik2025-Q299.685.77105.7Buyer-sourced0FAIL
AX-2025-020426MKM-2504-N4868Medutest2025-Q299.935.6297.9Buyer-sourced1FAIL
AX-2025-020427MKM-2504-N4868Kestrel2025-Q299.935.1595.4Buyer-sourced0FAIL
AX-2025-020428MKM-2504-N4868Nordanalyt2025-Q299.936.09Buyer-sourced0FAIL
AX-2025-020429MKM-2504-N4868PeptideMeter2025-Q299.875.26Buyer-sourced0PASS
AX-2025-020430MKM-2504-N4868PeptideMeter2025-Q299.725.44Buyer-sourced0PASS
AX-2025-020431MKM-2504-N4868PeptideMeter2025-Q299.765.50Buyer-sourced0FAIL
Other recent KPV records in the index.
ReportSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042742GGPepsGGPE-2511-K1569Janoshik2026-Q298.405.09Buyer-sourced0FAIL
AX-2026-042259TFCTFC-2508-M9624Janoshik2026-Q199.933.3889.4Buyer-sourced1FAIL
AX-2026-042078HYBHYB-2511-P7317Nordanalyt2026-Q199.593.9298.8Buyer-sourced0PASS
AX-2026-042262TFCTFC-2508-M9624Janoshik2026-Q199.893.3292.2Buyer-sourced0FAIL
AX-2026-042260TFCTFC-2508-M9624PeptideMeter2026-Q199.932.8999.2Buyer-sourced0FAIL
AX-2026-042079HYBHYB-2511-P7317Janoshik2026-Q199.685.6794.7Buyer-sourced0FAIL
AX-2026-042257TFCTFC-2508-M9624Janoshik2026-Q199.542.8195.6Buyer-sourced0FAIL
AX-2026-042261TFCTFC-2508-M9624Medutest2026-Q199.933.2097.1Buyer-sourced0FAIL
Other recent MKM records in the index.
ReportCompoundLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042942CJC-1295 (no DAC)MKM-2603-V3346Janoshik2026-Q399.523.43Supplier-supplied0PASS
AX-2026-043019AdipotideMKM-2606-K5012Janoshik2026-Q397.615.77105.1Buyer-sourced0PASS
AX-2026-042939CJC-1295 (no DAC)MKM-2603-V3346PeptideMeter2026-Q399.443.39Buyer-sourced0PASS
AX-2026-043020AdipotideMKM-2606-K5012Medutest2026-Q397.735.74Buyer-sourced0PASS
AX-2026-043022AdipotideMKM-2606-K5012Kestrel2026-Q397.696.33106.9Buyer-sourced0PASS
AX-2026-043023AdipotideMKM-2606-K5012Medutest2026-Q397.485.56103.7Supplier-supplied0PASS
AX-2026-042945CJC-1295 (no DAC)MKM-2603-V3346PeptideMeter2026-Q399.393.54Laboratory-retained0PASS
AX-2026-042938CJC-1295 (no DAC)MKM-2603-V3346Nordanalyt2026-Q399.473.6795.0Buyer-sourced0PASS